|Title||Bristol-Myers Squibb Conference Call on the Mead Johnson Split-Off|
|Date and Time||Monday, November 16, 2009 8:30 a.m. ET |
|Additional Information||In connection with the proposed disposition by Bristol-Myers Squibb of its interest in Mead Johnson via an exchange offer, Mead Johnson has filed with the Securities and Exchange Commission a registration statement that includes an exchange offer prospectus. Investors and security holders are urged to read carefully and in its entirety the prospectus, and any other relevant documents filed with the SEC, before making any investment decision. You can obtain a free copy of the prospectus and other related documents filed with the SEC by Bristol-Myers Squibb or Mead Johnson at the SEC’s web site at www.sec.gov. The prospectus may also be obtained for free from Mead Johnson at www.mjn.com.
This communication is for informational purposes only and is neither an offer to sell nor an offer to buy any securities or a recommendation as to whether you should participate in the exchange offer. The offer is made solely by the prospectus.